 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Component V: Clinical Studies: Defining Phenotypes and Early Treatment Trials
This component aims to refine, operationalize, and test the validity of phenotypes for genetic studies of adolescent antisocial drug dependence and comorbid conditions such as conduct disorder, ADHD, and depression. Additionally, by supporting early Stage I treatment trials this component aims to generate hypotheses for future grant applications addressing the roles of genes and environments in these disorders.
Principal Investigator:
Co-Investigators:
| component I | component II | component III | component IV | component VI |
 |
Division of Substance Dependence |  |
 |